Phase IIISmall Molecule
Compound 61700
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061700
Risk Class
LOW
Last Audit
Jun 19, 2108
Research Abstract
Small Molecule candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61700 is a small molecule asset inside small molecule innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase iii with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061700 with updates logged 2108-06-19.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61700Small Molecule Program 61700
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061700
- [2] Operations Pulse • Small Molecule innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61700